 1. Use of any concomitant disease modifying therapy for Multiple Sclerosis e.g. ß-interferon, glatiramer acetate or mitoxantrone, cyclophosphamide, methotrexate, azathioprine, or any other immuno-modulating e.g. IVIG or immunosuppressive drugs including recombinant or non-recombinant cytokines. 